First, to determine whether LSD1 inhibition influences specific gene methylation status, 22Rv1 cultured prostate cancer cells treated with NCL1 were subjected to chromatin immunoprecipitation (ChIP) assay. This evidence concerns the gene KDM1A and Familial prostate cancer.